Mantra Pharma Inc. (a publicly reporting company effective September 1, 2020) is developing its business plan in the Bio-Pharma & the Nutraceutical Sectors, to seek a listing on a Canadian Stock Exchange.
The Company is led by an accomplished, successful, and entrepreneurial business team operating under high standards of business conduct to build shareholder value.
The Company is seeking "Projects of Tomorrow" in the Health, Bio-Pharma and Nutraceutical sectors that are seeking benefits provided through a publicly listed company trading on a stock exchange.
Mantra Pharma Inc., collaborates with business innovators, entrepreneurs and research institutions in the biotech & nutraceutical industry who want to realize the market potential of their R&D investment, going public.
We believe in the value of biotech & nutraceutical research & development, the importance of a robust innovation ecosystem to support & be in the forefront of the latest scientific advances for the health benefit of society, worldwide.
We seek to empower businesses, offer guidance, expertise, and capabilities for sustainable long-term success.
We help bring great ideas and original products to global markets by providing structural financing, strategic guidance, infrastructure support and more
The global Nutraceutical products market’s value was USD 475,850 million in 2021, almost double its value in 2019. By 2030, it is expected to reach USD 1,033,520 million, growing at a CAGR of 9% over the forecast period 2022-2030.
Empowering Visionaries & Innovators
Mantra Pharma Inc.
Copyright © 2024 Mantra Pharma Inc. - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.